期刊文献+

新疆喀什地区汉族与维吾尔族心脑血管疾病患者CYP2C19基因多态性分析 被引量:6

Gene polymorphisms of CYP2C19 in cardiovascular and cerebrovascular diseases patients of Chinese Han and Uyghur populations in Kashi region of Xinjiang Uyghur Autonomous Region
下载PDF
导出
摘要 目的分析新疆喀什地区汉族、维吾尔族心脑血管疾病患者CYP2C19基因多态性。方法新疆喀什地区的1 020例心脑血管疾病患者,其中汉族220例、维吾尔族800例,采用基因芯片技术检测CYP2C19基因多态性,并对汉族和维吾尔族患者CYP2C19等位基因频率和代谢表型频率进行比较。结果汉族患者CYP2C19*1频率为0.645 4,维吾尔族患者为0.786 9,两者比较P<0.05;汉族患者*2频率为0.3273,维吾尔族患者为0.1837,两者比较P<0.05。汉族、维吾尔族患者代谢表型为强代谢型纯合子频率分别为42.72%、62.13%,两者比较P<0.01;强代谢型杂合子频率分别为43.64%、33.13%,两者比较P<0.01;弱代谢型频率分别为13.64%、4.76%,两者比较P<0.01。结论在新疆喀什地区汉族和维吾尔族心脑血管疾病患者中,CYP2C19的基因型分布具有差异。维吾尔族患者的强代谢基因型高于汉族患者,汉族患者的慢代谢基因型高于维吾尔族患者。 Objective To analyze the gene polymorphisms of CYP 2C19 in cardiovascular and cerebrovascular diseases patients of Chinese Han and Uyghur populations in Kashi region of Xinjiang Uyghur Autonomous Region .Methods We selected 1 020 patients with cardiovascular and cerebrovascular diseases , including 220 cases of Han population and 800 cases of Uyghur population .Using gene chip technology to detect CYP 2C19 gene polymorphism , and the genotype distribu-tion and frequencies of CYP2C19 between Han and Uyghur patients were compared .Results The frequency of CYP2C19*1 was 0.6454 in Han, 0.7869 in Uyghur (P〈0.05).The frequency of CYP2C19*2 was 0.3273 in Han, and 0.1837 in Uyghur (P 〈0.05).The homozygous frequencies of strong metabolic type in Han and Uyghur were 42.72% and 62.13%respectively, the heterozygous frequencies of strong metabolic type were 43.64% and 33.13% respectively and the frequencies of poor metabolic phenotype were 13.64%and 4.76%(all P〈0.01).Conclusions There is difference in the genotype distribution between Han and Uyghur population of patients with cardiovascular and cerebrovascular diseases in Kashi region of Xinjiang province .Uyghur population has higher frequency distribution in strong metabolic phenotype , but has lower frequency distribution in poor metabolic phenotype .
出处 《山东医药》 CAS 2014年第23期20-22,共3页 Shandong Medical Journal
基金 新疆维吾尔自治区科技支疆项目(201291168)
关键词 汉族 维吾尔族 CYP2C19基因 基因多态性 Han nationality Uyghur nationality CYP2C19 gene gene polymorphism
  • 相关文献

参考文献14

二级参考文献115

共引文献157

同被引文献41

  • 1陈騉,王睿,文思远,李健,王升启.用基因芯片技术测定健康人群P4502C9基因多态性[J].中国临床药理学杂志,2005,21(3):176-179. 被引量:10
  • 2胡祥鹏,黄庆科,马升高,吴明,吴金明,吴建胜.浙江省汉族人群CYP2C19基因多态性的分布特征[J].浙江医学,2009(10). 被引量:7
  • 3周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 4He N,Yan FX, Huang SL, et al. CYP2C19 genotype and S-me- phenytion 4-hydroxylation phenotype in a Chinese Dai population [ J]. Eur J Clin Pharmaco1,2002,58 ( 1 ) : 15-18. 被引量:1
  • 5Shimatarti T,lnoue M,Kuroiwa T,et al. Effect of omeprazole 10rag on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20mg and lafutidine 20mg, a new 1-12-receptor an- tagonist [ J ], Aliment Pharmacol Ther, 2003,18 ( 11-12 ) : 1149- 1157. 被引量:1
  • 6Gaziano TA, Bitton A, Anand S, et al. Growing epidemic of coronary heart disease in low- and middle-income countries [ J]. Curr Probl Car- diol,2010,35 (2) :72-115. 被引量:1
  • 7Sabatini MS, Cannon CP, Gibson CM, et al. Addition of clopidogrei as- pirin and fibrinolytie therapy for myocardial infarction with ST-segment elevation [ J ]. N Engl J Med,2005,352 ( 12 ) : 1179-1189. 被引量:1
  • 8Scott SA, Sangkuhl K, Stein CM, et al. Clinical Pharmacogenetics Im- plementation Consortium guideline for CYP2CI9 genotype and clopi- dogrel therapy :2013 update [ J ]. Clin Pharmacol Ther, 2013,94 ( 3 ) : 317-323. 被引量:1
  • 9He N,Yan FX, Huang SL, et al. CYP2C19 genotype and S-me-pheny- toin 4-hydroxylation phenotype in Chinese Dai population [ J ]. Aliment Pharmaeol Ther,2003,18 ( 11-12 ) : 1149-1157. 被引量:1
  • 10Pare G,'Mehta SR,Yusuf S ,Anand SS ,et al. Effects of CYP2C19 geno- type on outcomes of clopidogrel treatment [ J ]. N Engl J Med,2010,363 (18) :1704-1714. 被引量:1

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部